Revascularization in ischemic cardiomyopathy. Is viability testing still viable?
Rev Esp Cardiol (Engl Ed). 2024 Oct 24:S1885-5857(24)00309-8.
doi: 10.1016/j.rec.2024.10.004.
Online ahead of print.
[Article in
English,
Spanish]
Affiliations
- 1 Department of Cardiovascular Medicine, Mayo Clinic, Jacksonville, Florida, United States.
- 2 Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota, United States. Electronic address: Gersh.Bernard@mayo.edu.
No abstract available